Home › Studies › PRJNA1066476
PRJNA1066476 SRP484608

Gut microbiome in adults with active UC, Xiamen, China

Profiling the gut microbiome of patients with active ulcerative colitis received capsulized fecal microbiota transplantation

83 fecal WGS samples from adults with active ulcerative colitis in Xiamen, China, who received capsulized fecal microbiota transplantation, in a cross-sectional design. machine-written summary

83 samples · 83 runs · CN · Adult · 2024 · 6.01 Gbp / sample

Sources
✓Sequence archive 648✓Abstract / description 8○Full text○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive648 sample values (country, health condition, health condition detail, intervention, intervention detail, location locality, subject id, timepoint)
✓ Abstract / description8 sample values (health condition detail)
○ Full textread; no usable statement or table · PMC10269780, PMC9849685
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

before · no interventionbefore · no interventi28 samplesFMTFMT55 samples
single arm: samples before and on the intervention

20 people have samples in more than one arm.

Faecal microbiota transplantation design single_arm_before_after · population ulcerative_colitis · Capsulized fecal microbiota transplantation in active ulcerative colitis patients

“received capsulized fecal microbiota transplantation” — study.title (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 country
Age
adult83
Condition
ulcerative_colitis75
Country
CN83
Body site
primary83
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 81 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 2 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 6.01 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinalFMT donor → recipient — not resolved

21 of 29 people sampled more than once (75 samples; median 4, up to 4 per person) · follow-up median 3 mo (max 3 mo) · median interval between samples 21 d (time from timepoint labels). Schedule stated by the source: “Stool collected at W0 (baseline, before FMT), W1, W4, and W12 after capsulized FMT treatment” (time origin: intervention_start); stated follow-up 3 mo.

F1F1: day 0F1: day 7F1: day 28F1: day 84F10F10: day 0F10: day 7F10: day 28F12F12: day 0F12: day 7F12: day 84F13F13: day 0F13: day 7F13: day 28F13: day 84F14F14: day 0F14: day 7F14: day 84F15F15: day 0F15: day 7F15: day 28F15: day 84F16F16: day 0F16: day 7F16: day 28F16: day 84F17F17: day 0F17: day 7F17: day 28F17: day 84F18F18: day 0F18: day 7F18: day 28F19F19: day 0F19: day 7F19: day 28F19: day 84F2F2: day 0F2: day 7F2: day 28F2: day 84F20F20: day 0F20: day 7F20: day 28F20: day 84F21F21: day 0F21: day 7F21: day 28F21: day 84F22F22: day 0F22: day 7F22: day 28F3F3: day 0F3: day 7F3: day 28F3: day 84F4F4: day 0F4: day 7F4: day 28F4: day 84F5F5: day 0F5: day 7F6F6: day 0F6: day 84F7F7: day 0F7: day 7F7: day 28F7: day 84F8F8: day 0F8: day 7F8: day 28F8: day 84F9F9: day 0F9: day 7F9: day 28F9: day 840 d21 d42 d2 mo3 mo

Each row is one person (21 shown); dots are samples at days since that person's first sample.

8 sampled healthy donors; UC patients received capsulized FMT, each patient receiving flora from >=2 randomly assigned donors.

How longitudinal and relatedness information is derived

Community composition
Prevotella 29.6%Faecalibacterium 9.8%Phocaeicola 8.2%Escherichia 3.4%Hominicoprocola 3.2%Bifidobacterium 3.1%Bacteroides 2.9%Megamonas 2.6%Alistipes 2.4%Oscillibacter 2.1%Parasutterella 1.5%Collinsella 1.5%not assigned to a genus 8.2%other genera 21.5%

Genera, mean relative abundance over 80 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category83 100%
country83 100%83
health_condition75 90%75
subject_id83 100%83
detailed_location83 100%
health_condition_detail83 100%758
intervention83 100%83
intervention_detail83 100%83
location_locality83 100%83
timepoint_label83 100%83
Papers (2)
  • Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis. 2022 PMID 36683707 PMC9849685 own_data
  • Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation. 2023 PMID 37093057 PMC10269780 own_data
Details
Archive description

The goal of this study is to describe the profile of gut microbiome in adults with and without UC and to investigate the association between microbial composition and UC in China using fecal WGS.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “Profiling the gut microbiome of patients”
  • body site study.description · “the profile of gut microbiome in adults”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • life stage study.description · “gut microbiome in adults with and without”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN39488496countryCNR10.90sample.attr.geo_loc_nameChina:Xiamen
SAMN39488504health_conditionulcerative_colitisR10.85biosample.attribute:treatmenttreatment: FMT
SAMN39488504health_condition_detailFMTR10.85biosample.attribute:treatmenttreatment: FMT
SAMN39488496health_condition_detailmixed_case_control: ulcerative colitis patients vs healthy controlsR40.40study.descriptionadults with and without UC
SAMN39488496interventionno_interventionR10.90biosample.attribute:Group_RPGroup_RP: Donor1
SAMN39488504interventionno_interventionR10.90biosample.attribute:Treatment_stageTreatment_stage: Baseline
SAMN39488505interventionfmtR10.90biosample.attribute:Treatment_fmtTreatment_fmt: FMT
SAMN39488496intervention_detailFMT donor 1 sampleR10.90biosample.attribute:Group_RPGroup_RP: Donor1
SAMN39488504intervention_detailbaseline before FMT; assigned arm: FMT treatmentR10.90biosample.attribute:Treatment_stageTreatment_stage: Baseline
SAMN39488505intervention_detailFMT treatmentR10.90biosample.attribute:Treatment_fmtTreatment_fmt: FMT
SAMN39488496location_localityXiamenR10.85biosample.attribute:geo_loc_nameChina:Xiamen
SAMN39488496subject_idDonor1R10.85sample.attr.individualDonor1
SAMN39488496timepoint_labelDonorR10.85sample.attr.timeDonor
Sequencing

83 runs over 83 samples · mean 6.34 Gbp per run (median 6.01 Gbp, total 526.32 Gbp; 83 runs with a base count) · layout PAIRED 83 · platform ILLUMINA 83 · models Illumina MiniSeq (83) · 96% of runs with a Sandpiper profile · first public 2024-02-25

Authors (0)

No author record.

Downloads

PRJNA1066476.csv.gz (3.1 KB) · parquet (73.6 KB) — all 83 samples, every field with route and confidence · PRJNA1066476_determinations.csv.gz (4.8 KB) — 656 evidence rows

Samples (83 · every field this project has values for · hover a cell for its source)
Loading the sample table…